Viewing data from:

ALMOTRIPTAN MALATE

ANDA

ALMOTRIPTAN MALATE | A078027 | TEVA PHARMACEUTICALS USA

2 strengths0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 2 NDCs

Highest NADAC/Unit

$18.24

per ea

Lowest NADAC/Unit

$17.91

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
00093526018ALMOTRIPTAN MALATE 6.25 MG TAB	$18.24	EA	Generic	—	2026-06-17
00093526129ALMOTRIPTAN MALATE 12.5 MG TAB	$17.91	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain4 active DMFs2 inactive

4 active API suppliers hold Drug Master Files for this ingredient.

SMS PHARMACEUTICALS LTDALMOTRIPTAN MALATE

DMF 189622005

MATRIX PHARMACORP PRIVATE LTDALMOTRIPTAN MALATE USP

DMF 204242007

MSN LABORATORIES PRIVATE LTDALMOTRIPTAN MALATE USP [ROUTE CODE - AM]

DMF 253272011

ORCHID PHARMA LTDALMOTRIPTAN MALATE

DMF 261772012

RANKE QUIMICA SAInactiveALMOTRIPTAN, LAS 31416 D,L-HYDROGEN MALATE

DMF 124751997

APOTEX PHARMACHEM INDIA PVT LTDInactiveALMOTRIPTAN MALATE

DMF 252252011

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Jul 10, 2015	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (2)

Sort:

#001 — EQ 6.25MG BASE

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Jul 7, 2015

No patent or exclusivity listings for this strength.

#002 — EQ 12.5MG BASE

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Jul 7, 2015